Assoc Professor Lisa HuiPhD, GradCert Clin Epi, MBBS
Obstetrics and Gynaecology Royal Women's Hospital/Mercy
A/Prof Lisa Hui is an obstetrician with subspecialist qualifications in maternal fetal medicine. She completed her clinical training in obstetrics and gynaecology in Sydney and performed her PhD research at the Mother Infant Research Institute in Boston before moving to Melbourne in 2013. She has clinical appointments at the Mercy Hospital for Women, Heidelberg, and The Northern Hosptial, Epping, and is Associate Professor in the Department of Obstetrics and Gynaecology at the University of Melbourne. In 2016 she was awarded an NHMRC Early Career Fellowship and a Sylvia Charles Viertel Clinical investigatorship. She is a member of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Women's Health Committee, RANZCOG
Maternal Fetal Medicine subcommittee, and the Victorian Consultative Committee on Obstetric and Paediatric Morbidity and Mortality, Stillbirth subcommittee. She also serves in senior editorial roles with the scientific journals Ultrasound in Obstetrics and Gynecology and Prenatal Diagnosis
Clinical Professor Jon HyettMBBS BSc MD MRCOG FRANZCOG
Royal Prince Alfred Hospital | RPA · Department of Women and Babies
As a specialist in maternal and foetal medicine, Professor Jon Hyett looks after pregnancies that have a high risk of complication - either for the mother, or for the foetus.
Professor Hyett has worked at RPA for five years, having trained in obstetrics, maternal and foetal medicine in the UK before working in Australia. At Royal Prince Alfred, he leads a research group which has a strong clinical focus and a continual dedication to research to maintain the highest standards of obstetric care.
The group’s main research interest is to predict risk of pregnancy complication, either at an early stage (12 weeks), or immediately before delivery (at 36 weeks).
The group is currently working on a way to predict the risk of pre-eclampsia, a disease harmful to both the mother and foetus. If a risk is found at 12 weeks’ pregnancy, simple treatments like aspirin may prevent the onset of this disease.
Professor Hyett’s team is also leading the way in Australia with non-intrusive ways to screen pregnant women. A simple blood test can be used to define the foetus’ blood group by testing minute amounts of foetal DNA found in the mother. The group is on the cusp of a breakthrough by testing how this method may be used to screen for Down Syndrome, and other complications, at as early as 10 weeks into a pregnancy.
Through a National Health and Medical Research Council grant, the group is also studying the effect of rotating babies that are badly positioned during labour to reduce the rate of caesarean sections.
High risk obstetrics is a rewarding and diverse speciality for Professor Hyett who is constantly kept busy with the range of research needs this field demands.
Dr. George McGillivrayMBChB FCP(Paed)SA FRACP
Clinical Geneticist at Mercy Hospital for Women
George received his initial Fellowship in Paediatrics in South Africa in 1997, and holds specialist Fellowships in general paediatrics and in clinical genetics from Australia. He is a member of Genetics in the North East (GeNE) clinical network that incorporates genetic services at the Austin Hospital, the Mercy Hospital and the Northern Hospital. He also has appointments at the Royal Women’s Hospital, the Victorian Clinical Genetic Service and co-leads the neurogenetics clinic at the Royal Children’s Hospital.
His major research interest is in genetic conditions affecting the development of the fetal brain, particularly the corpus callosum. He brings his extensive clinical and academic expertise in prenatal genetics to our fetal neurology and general fetal medicine clinics. With his unique skill set spanning fetal and paediatric medicine, he is able to provide continuity of care for couples that are expecting a baby with a significant neurogenetic condition, accompanying their journey through pregnancy, the newborn period and providing long term follow up of their child's development.
Dr. Simon MeagherMB BCh BAO, BSc, FRCPI, FRCOG, FRANZCOG, DDU, COGU
Consultant Obstetrician/Gynaecologist & Sonologist
Monash Ultrasound for Women & Monash Medical Centre
◦ Medical Director Monash Ultrasound for Women (Current position)
◦ ISUOG Ambassador to Asia and Pacific region
◦ ISUOG International faculty of speakers
◦ ISUOG Joint Head of Courses committee
◦ ISUOG Online education committee
◦ ISUOG - VISUOG committee
◦ Lecturer Monash University (1996 – present)
◦ Honorary Lecturer University of Melbourne (1996 – 2003)
◦ Council Member, Australian Society for Ultrasound in Medicine (ASUM) (2007-2012)
◦ Chairman Standards of Practice Committee, Australian Society for Ultrasound in Medicine (2007 – 2012)
◦ Board Member, Diploma in Diagnostic Ultrasound (DDU) Australian Society for Ultrasound in Medicine (2005-2015)
◦ Examiner for Diploma in Diagnostic Ultrasound (DDU), Australian Society for Ultrasound in Medicine (2007-2012)
◦ Board Director, Monash Ultrasound for Women (Monash IVF Group, Australia) (2011 – 2015)
◦ Consultant Obstetrician Gynaecologist Sonologist, Mercy Hospital for Women (1996 – present)
◦ Consultant Sonologist Monash Ultrasound for Women (Current position)
◦ Chairman Melbourne (Victorian) Obstetric Sonologists (2010- 2014)
Dr Melody Menezes
BSc(Hons), GDipGenetCouns, PhD, MHGSA
Monash Ultrasound For Women genetic counselling department
Monash Ultrasound For Women genetic counselling department is lead by Dr Melody Menezes (BSc(Hons), GDipGenetCouns, PhD, MHGSA). Melody received her Doctorate of Philosophy in Medicine in 2011, studying fetal development and medicine, and genetic counselling.
Melody’s studies at The University of Melbourne also included her Graduate Diploma in Genetic Counselling (2007). Her undergraduate study at The University of Guelph Ontario, Canada saw her achieve Honours, majoring in molecular biology and genetics (2005).
Melody has held a position as Post-doctoral Research Officer at both the Murdoch Childrens Research Institute (Genetics Education and Health Research department) and the Victorian Clinical Genetics Service (Genetic Health Research). She has worked as Associate Genetic
Counsellor at the Royal Women’s Hospital, Melbourne and is in her 6th year as lecturer at The University of Melbourne, educating both undergraduates and masters students.
Melody’s role as an educator extends to national and international conferences and she has several publications in medical and counselling journals.
Of special interest to Melody is ethics in medicine, and prenatal screening and testing.
Dr. Jayshree RamkrishnaMBBS MD, FRANZCOG, DDU, COGU
Monash Ultrasound for Women
Dr Jayshree Ramkrishna is an Obstetrician Gynecologist (MD,FRANZCOG) . Her subspecialty training in ultrasound (DDU, COGU) was at Royal Women’s hospital and Monash Medical Center in Melbourne.
She currently works as a consultant in the Medical Imaging Department at Eastern Health (Melbourne) and at Monash Ultrasound For Women which is a private tertiary ultrasound practice specializing in women’s imaging.
Jayshree has a keen interest in ultrasound education and is examiner for the Australian Society of Ultrasound in Medicine and RANZCOG subspecialty examinations. Her area of expertise is in fetal medicine and gynecological ultrasound.
Dr. Daniel RolnikMSc, MD, PhD
Consultant Obstetrician Gynaecologist, Monash Medical Centre
Former Research Fellow of The Fetal Medicine Foundation
Dr Rolnik completed his Obstetrics and Gynaecology training at the University of São Paulo in Brazil. He then went on to work with Professor Kypros Nicolaides and undertook the Diploma in Fetal Medicine at the Fetal Medicine Foundation in London.
During this time, Dr Rolnik became involved in the ASPRE trial, a large scale randomised trial investigating the role of low dose aspirin in preventing pre-eclampsia in the context of a large first trimester screening program. The findings from this study, published recently in the New England Journal of Medicine, have the potential to lead to a paradigm shift not only in the prevention of pre-eclampsia, but also in the way antenatal care is delivered.
Dr Rolnik is currently working as a Maternal-Fetal Medicine Fellow at Monash Medical Centre
Dr. Tristan Hardy
MBBS (Hons I) MRMed FRANZCOG
Consultant Obstetrician/Gynaecologist, Repromed
Molecular Genetics and Cytogenetics, SA Pathology
Dr. Tristan Hardy is a consultant at Repromed and is undertaking training in genetic pathology at SA Pathology. His major interest is in the application of genomic technologies to all areas of reproductive and fetal medicine.
He has undertaken research in optimising preimplantation genetic testing for single gene disorders using next generation sequencing technology, and has a subspecialty clinic at Repromed with Dr. Jan Liebelt (Clinical Geneticist) reviewing patients who require preimplantation genetic testing.
He also consults to the Maternal Fetal Medicine Department at the Women's and Children's Hospital, Adelaide for issues relating to prenatal diagnosis and follow up of stillbirth and fetal abnormalities
Dr Fred Ushakov is an expert in Fetal Medicine & Echocardiography with over 30 years of experience in ultrasound and international practice within the world leading institutions.
Specialist in Fetal Medicine, University College London Hospital ISUOG Ambassador ISUOG International Faculty Member Director of the Ultrasound Network
I strongly believe that:
* All specialists in obstetric ultrasound must be able to diagnose severe congenital heart defects (CHD) as early as possible.
* Proper education in fetal echocardiography for every ultrasound practitioner will improve CHD detection rate and save many lives.
* Majority of severe CHD are detectable at 11-13 weeks scan and every trained doctor/sonographer can perform early cardiac diagnosis.
- Dr Fred Ushakov Founder of the London School of Ultrasound